C-suite remuneration across a dozen leading pharma companies in India rose in 2020-21 as top executives steered their organizations through pandemic-related disruptions and challenges to keep things moving. CEOs and managing directors of domestic firms continued to draw sizeably higher earnings overall versus their peers in foreign-listed entities in India.
Cadila Healthcare’s managing director Sharvil Patel, the son of chairman Pankaj Patel, led the earnings chart yet again, taking...